Core leadership
Gigi Hirsch, MD
Director
Center for Biomedical System Design & NEWDIGS;
Assistant Professor, Department of Medicine, TUSM
Gigi.Hirsch@tuftsmedicine.org
Sharon Phares, PhD, MPH
Associate Director for Research
sharon.phares@tuftsmedicine.org
Tom Hubbard, MPP
Policy Lead
tom.hubbard@tuftsmedicine.org
Eric Small
Program Manager
Eric.A.Small@tuftsmedicine.org
Strategic contributors
Jane F. Barlow, MD, MPH, MBA
EVP & CCO, Real Endpoints
Jane.Barlow@tuftsmedicine.org
Thomas F. Unger, PhD, MBA
Former ED, Pfizer
Mark Trusheim, MSc
President, Co-Bio Consulting, LLC
Mark.Trusheim@tuftsmedicine.org
Ronald Potts, MD
CMO, 6 Degrees Health
John Glasspool
CEO, VarmX
Alice Lin Pomponio, MPP
SVP, Corporate Development & Strategic Partnerships, Parker Institute for Cancer Immunotherapy
Harry Selker, MD, MSPH
Dean, CTSI & ICRHPS
Tufts University
Michael S. Sherman, MD, MBA, MS
Sherman Healthcare Solutions, LLC
Jay Schnitzer, MD, PhD
Former SVP, CTO, CMO, MITRE
Charles L. Cooney, PhD
Chemical Engineering, MIT
Nick Crabb, PhD
Program Director, Scientific Affairs, NICE
Michael A. Cusumano, PhD
MIT Sloan School of Management
Hans-Georg Eichler, MD, MSc
Assoc. of Austrian Social Insurance Institutions
Elazer Edelman, MD, PhD, FACC
Health Sciences and Technology Program, MIT
Andrew Lo, PhD
MIT Sloan School of Management
Kenneth A. Oye, PhD
MIT Program on Emerging Technologies
Alex 'Sandy' Pentland, PhD
MIT Media Lab Entrepreneurship Program
Richard Platt, MD, MSc
Harvard Pilgrim Health Care Institute
Peter Szolovits, PhD
Institute for Medical Engineering and Science (IMES), MIT
The role of the Executive Advisory Network is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities. The Executive Advisory Network will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.
Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Anne-Virginie Eggimann, MSc
Vice President, Regulatory Science bluebird bio
Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)
Hans-Georg Eichler, MD, MSc
Senior Medical Officer European Medicines Agency
Harry Selker, MD, MSPH
Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
David R. Strutton, PhD
Vice President of Global Pharmaceuticals and Policy Research, Center for Observational and Real-World Evidence, Merck & Co., Inc.
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Jane F. Barlow, MD, MPH, MBA
Senior Advisor, NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
Stella Blackburn, MD, MA, MSc
Senior Advisor, Regulatory Science, NEWDIGS; Honorary Associate Professor, London School of Hygiene & Tropical Medicine; Vice President, Global Head of Early Access and Risk Management, IQVIA
Jeff Brown, PhD
Assistant Professor, Department of Population Medicine, Harvard Medical School
Chester Drum, MD, PhD
Assistant Professor, Department of Medicine, National University of Singapore
R. John Glasspool
Senior Advisor, NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Judy Maro, PhD, MS
Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Nitin R. Patel, PhD
Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services
Casey Quinn, PhD
Research Advisor, NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
G.K. Raju, PhD
CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting